Genomic Research – The BioChain
SECTORS · GENOMIC RESEARCH

Genomic research infrastructure built for sensitivity, scale and sovereignty.

Genomic research increasingly happens across borders, across institutions and across regulatory regimes. The data is sensitive. The collaborations are political. The audit expectations are rising. Legacy research data systems were not built for this.

The trade-off legacy systems force.

Legacy research data systems force a trade-off between access, anonymity, sovereignty and integrity — a multi-jurisdiction collaboration typically means choosing which of those four properties to sacrifice. The BioChain is the infrastructure layer that resolves those trade-offs instead of forcing a choice between them.

Each research programme runs on its own chain instance, so institutions collaborate on a unified, verifiable record without any one party controlling it — and without local data residency requirements being compromised in the process.

Ten capabilities for cross-institution research.

01
Per-study chain instances
Each research programme runs on its own chain. No cross-contamination of data or access.
02
Patient tokenisation
Anonymised identifiers protect patients across the entire chain-of-custody.
03
Hash-on-chain, file-off-chain architecture
Sequence files stay in client-controlled storage; cryptographic hashes anchor integrity on-chain.
04
Multi-jurisdiction nodes
Local data residency preserved; unified verifiable view delivered.
05
Role-based access
Principal investigators, lab technicians, research teams and external auditors operate within defined boundaries.
06
Multi-site genomic research collaborations
A single verifiable record shared across collaborating institutions, each operating their own validating node.
07
Cross-border data sharing with sovereignty
Collaboration across jurisdictions without any single institution ceding control of its own data.
08
Sensitive sequence data management
Sequence files remain in client-controlled storage at all times, with integrity anchored rather than the raw data itself exposed.
09
Malaria, dengue and infectious disease genomics
Provenance infrastructure suited to exactly the kind of multi-institution, multi-jurisdiction collaboration infectious disease genomics depends on.
10
Gene-editing outcomes archives
A durable, verifiable record of outcomes that remains intact as research programmes, personnel and institutions change over time.

Why research consortia choose a Private BioChain.

Multi-institution research needs a record every collaborator trusts without any one institution controlling it — and without any institution having to give up sovereignty over its own data. A Private BioChain per study or per consortium keeps each institution's data under its own control while still delivering the unified, verifiable view the collaboration needs.

Wherever evidence must be trusted across systems.

Public health, agritech, food safety, environmental research — if your work depends on biological data integrity, we should talk.